Procaps Group, S.A EPS - Earnings per Share 2020-2023 | PROCF
Procaps Group, S.A eps - earnings per share from 2020 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Procaps Group, S.A Annual EPS |
| 2022 |
$0.42 |
| 2021 |
$-1.03 |
| 2020 |
$-0.11 |
| 2020 |
$-2.78 |
| 2019 |
$-0.18 |
| 2019 |
$0.00 |
| 2018 |
$0.00 |
| Procaps Group, S.A Quarterly EPS |
| 2023-09-30 |
$0.08 |
| 2023-06-30 |
$0.27 |
| 2023-03-31 |
$0.07 |
| 2022-12-31 |
$0.11 |
| 2022-09-30 |
$0.22 |
| 2022-06-30 |
$-0.07 |
| 2022-03-31 |
$0.16 |
| 2021-12-31 |
$0.30 |
| 2021-09-30 |
$-1.14 |
| 2021-06-30 |
$-0.01 |
| 2021-03-31 |
$-0.18 |
| 2020-12-31 |
$-1.22 |
| 2020-09-30 |
$0.00 |
| 2020-06-30 |
$-0.76 |
| 2020-03-31 |
$0.36 |
| 2019-12-31 |
$-0.47 |
| 2019-09-30 |
$0.00 |
| 2019-06-30 |
$0.00 |
| 2019-03-31 |
$-5.50 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$0.125B |
$0.410B |
|
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.
|
